March 10, 2026 · Form 4 insider transaction
Huston Thad Allen bought 220,000 shares of Artiva Biotherapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Represents restricted stock unit award granted under the Issuer's 2025 Inducement Plan.